Company Update

Genpharmasec Limited has announced the Annual Secretarial Compliance Report for the year ended March 31, 2025, confirming full adherence to all applicable corporate governance and SEBI regulations without any deviations or penalties.

The report highlights that the company maintains up-to-date policies, conducts performance evaluations of its board and committees, and complies with disclosure and insider trading requirements.

No directors are disqualified, no material subsidiaries exist, and no actions have been taken against the company or its promoters by regulatory authorities.

This demonstrates strong regulatory compliance and governance oversight, supporting shareholder confidence in its operations.